SRF Limited — Updates, 20-01-2026: Press Release
20-01-2026 | 03:23 pm
20-01-2026 | 03:23 pm
SRF Q3FY26 PAT soared 60% to ₹433 Cr, driven by robust Chemicals Business growth (revenue +22%). Fluorochemicals achieved record performance. The board approved a ₹5/share interim dividend and a ₹180 Cr capex for a new Pharma Intermediates plant.
No comments yet. Be the first to comment!
